Salem M. Al-Kanaimsh

Alkanaimsh, S., Alsalal, A. M., & El-Touney, H. (2024). Technoeconomic Analysis of Intensified PEGylated Biopharmaceutical Recombinant Protein Production: Alpha Antitrypsin as a Model Case. Processes, 12(5), 979. 

Alkanaimsh, S., Corbin, J. M., Kailemia, M. J., Karuppanan, K., Rodriguez, R. L., Lebrilla, C. B., . . . Nandi, S. (2019). Purification and site-specific N-glycosylation analysis of human recombinant butyrylcholinesterase from Nicotiana benthamiana. Biochemical Engineering Journal, 142, 58-67. 

Corbin, J. M., Kailemia, M. J., Cadieux, C. L., Alkanaimsh, S., Karuppanan, K., Rodriguez, R. L., . . . Nandi, S. (2018). Purification, characterization, and N‐glycosylation of recombinant butyrylcholinesterase from transgenic rice cell suspension cultures. Biotechnology and bioengineering, 115(5), 1301-1310. 

Karuppanan, K., Alkanaimsh, S., Silberstein, D., Bernardi, A., Guerrero, A., Wang, Q., . . . Eiserich, J. (2018). Effect of N-glycosylation of recombinant alpha-1 antitrypsin therapeutic protein structure and function: A biophysical and molecular dynamic simulation study. In A75. COPD: TARGETS, MODELS, AND CLINICAL STUDIES (pp. A2405-A2405): American Thoracic Society.

Alkanaimsh, S., Corbin, J., Karuppanan, K., Kailemia, M., Lebrilla, C., Rodriguez, R., . . . McDonald, K. (2017). Downstream processing development of Nicotiana benthamiana based recombinant butyrylcholinesterase. Paper presented at the ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.